Header cover image

Israeli (TA) Drug Retail Industry Analysis

UpdatedMay 01, 2024
DataAggregated Company Financials
Companies1
  • 7D2.6%
  • 3M26.4%
  • 1Y49.5%
  • YTDn/a

In the last week, the Drug Retail industry is up 6.3%, with all of the companies up. This takes the industry's 12 month performance to a gain of 68%.

Industry Valuation and Performance

Has the Israeli Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 May 2024₪134.1m₪142.0k-₪5,932,000.00n/a-22.6x944.5x
Sat, 30 Mar 2024₪56.1m₪142.0k-₪5,932,000.00n/a-9.4x394.7x
Mon, 26 Feb 2024₪105.9m₪127.0k-₪15,596,000.00n/a-6.8x833.7x
Wed, 24 Jan 2024₪112.8m₪127.0k-₪15,596,000.00n/a-7.2x888x
Fri, 22 Dec 2023₪107.0m₪127.0k-₪15,596,000.00n/a-6.9x842.2x
Sun, 19 Nov 2023₪92.1m₪127.0k-₪15,596,000.00n/a-5.9x725x
Tue, 17 Oct 2023₪75.0m₪127.0k-₪15,596,000.00n/a-4.8x590.9x
Thu, 14 Sep 2023₪33.6m₪127.0k-₪15,596,000.00n/a-2.2x264.5x
Sat, 12 Aug 2023₪36.3m₪60,000.00-₪19,025,000.00n/a-1.9x604.6x
Mon, 10 Jul 2023₪43.0m₪60,000.00-₪19,025,000.00n/a-2.3x717.2x
Wed, 07 Jun 2023₪48.4m₪60,000.00-₪19,025,000.00n/a-2.5x806.7x
Fri, 05 May 2023₪39.7m₪60,000.00-₪19,025,000.00n/a-2.1x660.9x
Sun, 02 Apr 2023₪45.6m₪60,000.00-₪19,025,000.00n/a-2.4x760.3x
Tue, 28 Feb 2023₪45.0m₪211.0k-₪15,253,000.00n/a-3x213.4x
Thu, 26 Jan 2023₪51.6m₪211.0k-₪15,253,000.00n/a-3.4x244.5x
Sat, 24 Dec 2022₪57.1m₪211.0k-₪15,253,000.00n/a-3.7x270.8x
Mon, 21 Nov 2022₪51.8m₪211.0k-₪15,253,000.00n/a-3.4x245.4x
Wed, 19 Oct 2022₪83.2m₪211.0k-₪15,253,000.00n/a-5.5x394.2x
Fri, 16 Sep 2022₪43.1m₪658.0k-₪23,361,000.00n/a-1.8x65.6x
Sun, 14 Aug 2022₪25.7m₪658.0k-₪23,361,000.00n/a-1.1x39.1x
Tue, 12 Jul 2022₪24.3m₪658.0k-₪23,361,000.00n/a-1x37x
Thu, 09 Jun 2022₪34.4m₪658.0k-₪23,361,000.00n/a-1.5x52.3x
Sat, 07 May 2022₪35.2m₪658.0k-₪23,361,000.00n/a-1.5x53.5x
Mon, 04 Apr 2022₪28.6m₪658.0k-₪23,361,000.00n/a-1.2x43.5x
Wed, 02 Mar 2022₪29.9m₪29.4m-₪21,319,000.00n/a-1.4x1x
Fri, 28 Jan 2022₪31.7m₪29.4m-₪21,319,000.00n/a-1.5x1.1x
Sun, 26 Dec 2021₪36.4m₪29.4m-₪21,319,000.00n/a-1.7x1.2x
Tue, 23 Nov 2021₪44.4m₪29.4m-₪21,319,000.00n/a-2.1x1.5x
Thu, 21 Oct 2021₪51.8m₪29.4m-₪21,319,000.00n/a-2.4x1.8x
Sat, 18 Sep 2021₪50.4m₪29.4m-₪21,319,000.00n/a-2.4x1.7x
Mon, 16 Aug 2021₪68.6m₪29.4m-₪21,319,000.00n/a-3.2x2.3x
Mon, 31 May 2021₪73.4m₪23.7m-₪15,064,000.00n/a-4.9x3.1x
Price to Earnings Ratio

-4.8x


Total Market Cap: ₪71.9mTotal Earnings: -₪15,064,000.00Total Revenue: ₪23.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Drug Retail Industry Price to Earnings3Y Average -3.7x202220232024
Current Industry PE
    There is only one company in the Israeli Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 82% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Israeli Drug Retail compare with similar industries?

IL Market-0.15%
Consumer Staples0.53%
Food and Staples Retail1.65%
Drug Retail2.64%
Food Retail1.77%
Food Distributors0.60%
Big Box Super Stores0%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GEFR Geffen Residence & Renewal₪0.630.2%
+₪215.6k
52.0%PS958.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GEFR

₪0.63

Geffen Residence & Renewal

7D

0.2%

1Y

52.0%